Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stanke

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Odontologia Chilena|April 1, 1989
[Reinforced glass ionomer restorations in modified Class II cavities]V Valenzuela, F Stanke
La Revue De Medecine Interne|August 6, 1999
[Endothelin-1 and cardiovascular diseases]J L Cracowski, F Stanke, G Bessard
Journal of Chromatography. B, Biomedical Applications|January 12, 1996
Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detectionF Stanke, N Jourdil, J Bessard, et al.
La Revue De Medecine Interne|April 14, 2000
[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects]J L Cracowski, F Stanke-Labesque, G Bessard
Therapie|August 21, 2002
[Leukotrienes and 12-HETE: key mediators of angiotensin II-mediated vascular effects.Rol in hypertension]F Stanke-Labesque, G Hardy, J L Cracowski, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Isoprostanes: new markers of oxidative stress in human diseases]J L Cracowski, F Stanke-Labesque, C Souvignet, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassayJ Bessard, J L Cracowski, F Stanke-Labesque, et al.
Therapie|March 1, 1996
[Macrolides and drug interactions: review of the literature]V Lauby, M Mallaret, I Dufrêne, et al.
Fundamental & Clinical Pharmacology|February 19, 2000
Are isoprostanes a clinical marker for antioxidant drug investigation?C Souvignet, J L Cracowski, F Stanke-Labesque, et al.
Therapie|June 22, 2000
[In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]F Stanke-Labesque, J L Cracowski, P Devillier, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Odontologia Chilena|April 1, 1989
[Reinforced glass ionomer restorations in modified Class II cavities]V Valenzuela, F Stanke
La Revue De Medecine Interne|August 6, 1999
[Endothelin-1 and cardiovascular diseases]J L Cracowski, F Stanke, G Bessard
Journal of Chromatography. B, Biomedical Applications|January 12, 1996
Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detectionF Stanke, N Jourdil, J Bessard, et al.
La Revue De Medecine Interne|April 14, 2000
[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects]J L Cracowski, F Stanke-Labesque, G Bessard
Therapie|August 21, 2002
[Leukotrienes and 12-HETE: key mediators of angiotensin II-mediated vascular effects.Rol in hypertension]F Stanke-Labesque, G Hardy, J L Cracowski, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2000
[Isoprostanes: new markers of oxidative stress in human diseases]J L Cracowski, F Stanke-Labesque, C Souvignet, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassayJ Bessard, J L Cracowski, F Stanke-Labesque, et al.
Therapie|March 1, 1996
[Macrolides and drug interactions: review of the literature]V Lauby, M Mallaret, I Dufrêne, et al.
Fundamental & Clinical Pharmacology|February 19, 2000
Are isoprostanes a clinical marker for antioxidant drug investigation?C Souvignet, J L Cracowski, F Stanke-Labesque, et al.
Therapie|June 22, 2000
[In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]F Stanke-Labesque, J L Cracowski, P Devillier, et al.
Pageof 5